274 related articles for article (PubMed ID: 7046914)
1. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
Hales BF
Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
[No Abstract] [Full Text] [Related]
2. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
3. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
5. Teratogenicity of cyclophosphamide metabolites: phosphoramide mustard, acrolein, and 4-ketocyclophosphamide in rat embryos cultured in vitro.
Mirkes PE; Fantel AG; Greenaway JC; Shepard TH
Toxicol Appl Pharmacol; 1981 Apr; 58(2):322-30. PubMed ID: 7245204
[No Abstract] [Full Text] [Related]
6. The role of reactive metabolites in drug-induced teratogenesis.
Hales BF; Slott VL
Prog Clin Biol Res; 1987; 253():181-91. PubMed ID: 3432286
[No Abstract] [Full Text] [Related]
7. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
Kawabata TT; White KL
Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
[TBL] [Abstract][Full Text] [Related]
8. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
Hales BF
Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Crook TR; Souhami RL; McLean AE
Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
[TBL] [Abstract][Full Text] [Related]
10. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
11. Relative mutagenicity and teratogenicity of cyclophosphamide and two of its structural analogs.
Hales BF
Biochem Pharmacol; 1983 Dec; 32(24):3791-5. PubMed ID: 6362674
[TBL] [Abstract][Full Text] [Related]
12. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
Little SA; Mirkes PE
Teratology; 1990 Feb; 41(2):223-31. PubMed ID: 2321166
[TBL] [Abstract][Full Text] [Related]
13. Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes.
Wilmer JL; Erexson GL; Kligerman AD
Cancer Res; 1990 Aug; 50(15):4635-8. PubMed ID: 2369740
[TBL] [Abstract][Full Text] [Related]
14. Denaturation of cytochrome P-450 by cyclophosphamide metabolites.
Marinello AJ; Gurtoo HL; Struck RF; Paul B
Biochem Biophys Res Commun; 1978 Aug; 83(4):1347-53. PubMed ID: 697865
[No Abstract] [Full Text] [Related]
15. Role of the 4-hydroxy intermediate in the in vitro embryotoxicity of cyclophosphamide and dechlorocyclophosphamide.
Slott VL; Hales BF
Toxicol Appl Pharmacol; 1988 Feb; 92(2):170-8. PubMed ID: 3341031
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
Sladek NE; Doeden D; Powers JF; Krivit W
Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951
[TBL] [Abstract][Full Text] [Related]
17. In vitro methods for the study of the effects of teratogens on preimplantation embryos.
Spielmann H; Eibs HG; Jacob-Müller U
Acta Morphol Acad Sci Hung; 1980; 28(1-2):105-15. PubMed ID: 7446214
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the embryotoxicity of acrolein, but not phosphoramide mustard, by glutathione depletion in rat embryos in vitro.
Slott VL; Hales BF
Biochem Pharmacol; 1987 Jun; 36(12):2019-25. PubMed ID: 3593406
[TBL] [Abstract][Full Text] [Related]
19. The effect of oxygen concentration on the teratogenicity of salicylate, niridazole, cyclophosphamide, and phosphoramide mustard in rat embryos in vitro.
Greenaway JC; Mirkes PE; Walker EA; Juchau MR; Shepard TH; Fantel AG
Teratology; 1985 Oct; 32(2):287-95. PubMed ID: 4049287
[TBL] [Abstract][Full Text] [Related]
20. Half-life of oxazaphosphorines in biological fluids.
Sladek NE; Powers JF; Grage GM
Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
